SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yolande Berthois, Christine Delfino, Philippe Metellus, Frederic Fina, Isabelle Nanni-Metellus, Hayat Al Aswy, Victor Pirisi, L’Houcine Ouafik, Françoise Boudouresque, Differential expression of miR200a-3p and miR21 in grade II–III and grade IV gliomas: Evidence that miR200a-3p is regulated by O6-methylguanine methyltransferase and promotes temozolomide responsiveness, Cancer Biology & Therapy, 2014, 15, 7, 938

    CrossRef

  2. 2
    Michela Visani, Dario de Biase, Gianluca Marucci, Serenella Cerasoli, Evandro Nigrisoli, Maria Letizia Bacchi Reggiani, Fiorenzo Albani, Agostino Baruzzi, Annalisa Pession, Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III, Molecular Oncology, 2014, 8, 2, 417

    CrossRef

  3. 3
    Rui Li, Kaiming Gao, Hui Luo, Xiefeng Wang, Yan Shi, Qingsheng Dong, WenKang Luan, Yongping You, Identification of intrinsic subtype-specific prognostic microRNAs in primary glioblastoma, Journal of Experimental & Clinical Cancer Research, 2014, 33, 1, 9

    CrossRef

  4. 4
    Michael Henriksen, Kasper Bendix Johnsen, Hjalte Holm Andersen, Linda Pilgaard, Meg Duroux, MicroRNA Expression Signatures Determine Prognosis and Survival in Glioblastoma Multiforme—a Systematic Overview, Molecular Neurobiology, 2014,

    CrossRef

  5. 5
    Kai-Liang Zhang, Xuan Zhou, Lei Han, Lu-Yue Chen, Ling-Chao Chen, Zhen-Dong Shi, Ming Yang, Yu Ren, Jing-Xuan Yang, Thomas S Frank, Chuan-Bao Zhang, Jun-Xia Zhang, Pei-Yu Pu, Jian-Ning Zhang, Tao Jiang, Eric J Wagner, Min Li, Chun-Sheng Kang, MicroRNA-566 activates EGFR signaling and its inhibition sensitizes glioblastoma cells to nimotuzumab, Molecular Cancer, 2014, 13, 1, 63

    CrossRef

  6. 6
    Zhao-Shi Bao, Ming-Yang Li, Jia-Yin Wang, Chuan-Bao Zhang, Hong-Jun Wang, Wei Yan, Yan-Wei Liu, Wei Zhang, Ling Chen, Tao Jiang, Prognostic Value of a Nine-Gene Signature in Glioma Patients Based on mRNA Expression Profiling, CNS Neuroscience & Therapeutics, 2014, 20, 2
  7. 7
    Hong-Bin Cheng, Wu Yue, Chen Xie, Ru-You Zhang, Shao-Shan Hu, Zhi Wang, IDH1 mutation is associated with improved overall survival in patients with glioblastoma: a meta-analysis, Tumor Biology, 2013, 34, 6, 3555

    CrossRef

  8. 8
    Zheng Wang, Zhaoshi Bao, Wei Yan, Gan You, Yinyan Wang, Xuejun Li, Wei Zhang, Isocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild type, Journal of Experimental & Clinical Cancer Research, 2013, 32, 1, 59

    CrossRef

  9. 9
    Kenneth KW To, MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapy, Journal of Biomedical Science, 2013, 20, 1, 99

    CrossRef

  10. 10
    Ana Xavier-Magalhães, Meera Nandhabalan, Chris Jones, Bruno M Costa, Molecular prognostic factors in glioblastoma: state of the art and future challenges, CNS Oncology, 2013, 2, 6, 495

    CrossRef

  11. 11
    Zhao-Shi Bao, Chuan-Bao Zhang, Hong-Jun Wang, Wei Yan, Yan-Wei Liu, Ming-Yang Li, Wei Zhang, Whole-Genome mRNA Expression Profiling Identifies Functional and Prognostic Signatures in Patients with Mesenchymal Glioblastoma Multiforme, CNS Neuroscience & Therapeutics, 2013, 19, 9